Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 11/20 | 0.56 |
| ▸ | PTPN2 | P17706 | 5/20 | 0.55 |
| ▸ | PTPN6 | P29350 | 4/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | STAT1 | P42224 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7078511 | 0.80 | KDM4E (0.72) | KDM4EALDH1A1HPGDSMN1; SMN2PTPN1 | |
| SCHEMBL2603426 | 0.80 | KDM4E (0.72) | KDM4EALDH1A1HPGDSMN1; SMN2PTPN1 | |
| SCHEMBL30377760 | 0.79 | ALDH1A1 (0.62) | KDM4EALDH1A1HPGDSMN1; SMN2PTPN1 | |
| SCHEMBL9606209 | 0.79 | ALDH1A1 (0.62) | KDM4EALDH1A1HPGDSMN1; SMN2PTPN1 | |
| SCHEMBL1180905 | 0.78 | KDM4E (0.72) | KDM4EALDH1A1HPGDSMN1; SMN2PTPN1 | |
| SCHEMBL4871472 | 0.77 | KDM4E (1.00) | KDM4EALDH1A1HPGDSMN1; SMN2PTPN1 | |
| SCHEMBL2603403 | 0.74 | KDM4E (0.56) | KDM4EALDH1A1HPGDSMN1; SMN2PTPN1 | |
| SCHEMBL4880206 | 0.74 | KDM4E (0.89) | KDM4EALDH1A1HPGDSMN1; SMN2PTPN1 | |
| SCHEMBL31288126 | 0.74 | PTPN1 (0.55) | KDM4EALDH1A1HPGDSMN1; SMN2PTPN1 | |
| SCHEMBL10909733 | 0.73 | TSHR (0.74) | KDM4EALDH1A1HPGDSMN1; SMN2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120136029-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 2-ARYL PYRIDYLAZOLES | UNIVERSITY OF ARIZONA (US) | 2012-05-31 | — | — | US | disclosed |
| US-20120136029-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 2-ARYL PYRIDYLAZOLES | UNIVERSITY OF ARIZONA (US) | 2012-05-31 | — | — | US | disclosed |
| WO-2010121243-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 2-ARYL PYRIDYLAZOLES | UNIVERSITY OF ARIZONA (US) | 2010-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136029-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 2-ARYL PYRIDYLAZOLES | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CDK2, CCNC | KDM4E 2610/4885ALDH1A1 1378/4885HPGD 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.